baber/WOPTO huggingface dataset:
Patent NZ-536671-A (NZ)
Title: Beverage dispenser with system to prevent deterioration of quality
Inventor: YOSHIDA EIJI
IPC: G01F11/32
Filed: 2003-05-23
Abstract: A nip dispenser 60 to dispense apportioned quantities of particularly wine from a bottle B1, the wine being subject to deterioration if allowed to contact air in the bottle, includes a liquid storage portion for storing liquid supplied from the upturned bottle via the down flow valve press fitted into the neck of the bottle, a dispensing portion with a dispensing valve positioned beneath the device body and which allows the liquid to flow from the liquid storage portion to the outside, and a gas supply port 81 through which a deterioration preventative gas (e.g. nitrogen gas) is supplied into the liquid storage portion. A valve driver rod 75 includes upper and lower driving portions for respectively operating the down flow valve and the dispensing valve. An operating portion 72 operates the valve driver by external actuation to move the valve driver upwardly from a neutral position to open the down flow valve to allow liquid to flow from the bottle into the storage portion, and displacing gas to be supplied into the bottle, whilst the dispensing valve is closed, and to move the valve driver downwardly from the upward position via the neutral position to a second position to open the dispensing valve whilst the down flow valve is closed.
Patent NZ-536686-A (NZ)
Title: Method for determining cure in a polycarboxylic acid bindered material
Inventor: CHEN LIANG
IPC: G01N31/22
Filed: 2003-05-12
Abstract: Disclosed is a method determining the amount of binder cure in a polycarboxylic acid based binder coated fibreglass article comprising: Providing a coated fibreglass network, said network comprising a plurality of glass fibers coated with a polycarboxylic acid based binder; Introducing said coated fibreglass network to a curing oven; Heating said coated fibreglass network within said curing oven for a first period of time at a first temperature to cure said polycarboxylic acid binder to said network to form the polycarboxylic acid based binder coated fibreglass article, said first period of time and said first temperature defining a binder curing rate of said polycarboxylic acid binder; Removing said coated fibreglass network from said curing oven; Applying pH indicator solution to a binder surface of the polycarboxylic acid based binder coated fibreglass article; Determining a pH of said binder surface as a function of said pH indicator solution; and Determining an amount of cure of said binder surface as a function of said pH.
Patent NZ-536746-A (NZ)
Title: An agonistic antibody or fragment thereof that immunospecifically binds and stimulates the human OX40-receptor
Inventor: BAKKER ALEXANDER BERTHOLD HEND
IPC: A61K51/10
Filed: 2003-06-13
Abstract: An agonistic antibody or fragment thereof that immunospecifically binds and stimulates the human OX40-receptor. Also disclosed are nucleic acids encoding the antibodies. The antibodies and nucleic acids are useful in the stimulation of human T-cells.
Patent NZ-539542-A (NZ)
Title: Novel process for the preparation of roflumilast
Inventor: KOHL BERNHARD
IPC: C07D213/75
Filed: 2004-03-08
Abstract: Disclosed are processes for the preparation of high-purity roflumilast. The process involves reacting the anion of 4-armino-3,5-dichloropyridine of formula (I) with an activated derivative of 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid of formula (II), characterized in that the molar ratio of the employed anion of 4-amino-3,5-dichloropyridine to the activated derivative of 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid is at least 1.8 and at most 2.7.
Patent NZ-539993-A (NZ)
Title: A hybrid structural module
Inventor: VAN ERP GERARDUS MARIA
IPC: E04C5/07
Filed: 2003-11-13
Abstract: A hybrid structural module (10) comprising a tubular fibre composite member (20), a filled resin system (30) located within said tubular fibre composite member, and at least one elongated steel member (40) located within the filled resin system, wherein the filled resin system binds the steel member and tubular member together.
Patent NZ-540497-A (NZ)
Title: Method of treating sepsis-induced ards using tetracycline compounds
Inventor: SIMON SANFORD R
IPC: A61K31/65
Filed: 2003-11-07
Abstract: Disclosed is a use of a tetracycline compound in the manufacture of a medicament for preventing clinically relevant sepsis-induced acute respiratory distress syndrome (ARDS) in a human, wherein the source of the sepsis is an intact microbe, wherein the medicament is formulated to administer the tetracycline compound in an amount that is effective to prevent sepsis-induced ARDS but has substantially no antibiotic activity, and wherein the medicament is to be administered after the onset of systemic inflammatory response syndrome and before the onset of ARDS. Also disclosed is a use of a tetracycline compound in the manufacture of a medicament for preventing ARDS precipitated by the inhalation of toxic gas in a mammal, wherein the medicament is formulated to administer the tetracycline compound in an amount that is effective to prevent ARDS precipitated by the inhalation of toxic gas but has substantially no antibiotic activity, wherein the medicament is to be administered after inhalation of the toxic gas and before the onset of ARDS.
Patent NZ-541025-A (NZ)
Title: Artificial neural network guessing method and game
Inventor: BURGENER ROBIN
IPC: A63F13/00
Filed: 2005-06-29
Abstract: A method of operating a neural network to provide a method for guessing an object that the user of an electronic game is thinking of is disclosed. The neural network is structured in a target objects-by-questions matrix and each cell of the matrix defines an input-output connection weight. The network can be operated in two modes, the first mode uses answers to previously asked questions as the input nodes and the target objects as the output nodes, while the second mode has the target objects as the input nodes and the questions as the output nodes. The method involves ranking the target objects by using the network in the first mode, ranking the questions by using the network in the second mode, and providing a guess according to the ranking of the target objects.
Patent NZ-544416-A (NZ)
Title: Interface for voucher and coupon printing
Inventor: BROOKS DONALD E
IPC: G06F3/12
Filed: 2003-11-25
Abstract: A method for driving a printer from a local controller and a central controller, and an interface for driving the printer is disclosed. The method and interface have particular application to printing highly secure vouchers and less secure coupons where the printer can reside in a wagering terminal (e.g., slot machine), ticket machine, or point-of-sale terminal or the like. Coupons do not have to be processed by the secure (and usually proprietary) hardware and/or software provided by the terminal manufacturer for printing vouchers. The method involves monitoring communications from the local and central controllers, determining the availability of the printer when a communication from one of the controllers, and if the printer is available then decoding the printer data into one format and converting the decoded data into standard printer format for communication to the printer. If the printer is not available then notification is sent to the communicating controller that the printer is busy.
Patent NZ-544645-A (NZ)
Title: Use of calcitonin in osteoarthritis
Inventor: AZRIA MOISE
IPC: A61K47/16
Filed: 2004-07-22
Abstract: Provided is the use of calcitonin in the manufacture of an oral medicament for preventing and/or treating osteoarthritis and preserving/stimulating cartilage in a human patient, wherein the medicament comprises an amount of calcitonin of from 0.4 to 2.5 mg, the medicament further comprising a delivery agent, for the calcitonin, of N-(5-chlorosalicyloyl)-8amino caprylic acid (5-CNAG) and similar compounds. Further provided is similar use in which the delivery agent is in micronised form.
Patent NZ-545769-A (NZ)
Title: Improvements in or relating to drains
Inventor: KNIGHT RODNEY PAUL
Filed: 2006-03-08
Abstract: A connection comprising a first female member and a second male member is disclosed. The connection has engageable threads on the inner surface of the female member and the outer surface of the male member, and at least one slot formed in the threads on the inner surface of the female member. The slot or slots extend substantially longitudinally of the female member and/or the male member, where each slot has a depth greater than the depth of the threads on the male member so that when the male member is engaged in the female member, a passageway or passageways past the threads is provided by the slot or slots.
Patent NZ-547067-A (NZ)
Title: Method of forming thermoplastic foams using nano-particles to control cell morphology
Inventor: RYND JOSEPH P
IPC: C08J9/00
Filed: 2004-11-22
Abstract: Disclosed is a process for making closed-cell, alkenyl aromatic polymer foams using nano-particle nucleation agents to control the cell morphology of the resulting foam. The process includes forming a polymer melt at a temperature above the polymer glass transition temperature (for crystal polymers) or the polymer melt point (for amorphous polymers); incorporating selected nano-particles into the polymer melt; incorporating blowing agents into the polymer melt at an elevated pressure; optionally incorporating other additives, such as flame retardants, into the polymer melt; and extruding the polymer melt under conditions sufficient to produce a foam product having a desired cell morphology.
Patent NZ-550970-A (NZ)
Title: Medical adhesive and methods of tissue adhesion
Inventor: BECKMAN ERIC J
IPC: C08G18/00
Filed: 2004-05-27
Abstract: Disclosed is the use of a moisture-curable, isocyanate-functional composition in the manufacture of an adhesive for adhering tissue, the isocyanate-functional composition comprising the reaction product of a reaction mixture consisting essentially of: (a) a stoichiometric excess of multi-isocyanate functional molecules derived from multi-functional amino acid precursors; and (b) a multi-functional reactant selected from the group consisting of a saccharide, a polysaccharide, a steroid, glycerol, ascorbic acid, an amino acid, and combinations thereof, the multi-functional reactant having at least two isocyanate-reactive functional groups, wherein the reaction product has an average isocyanate functionality of at least 2.1.
Patent NZ-552133-A (NZ)
Title: Fermentation process using FABA beans as nitrogen source
Inventor: DEFACHELLES AURELIA
IPC: C12P1/00
Filed: 2005-06-15
Abstract: Disclosed is a process for the preparation of microbial biomass and/or a valuable compound comprising fermentation of a filamentous microorganism in a medium comprising a complex nitrogen source, wherein at least 50% of the nitrogen (N) that is supplied by the complex nitrogen source is provided by faba bean meal. Also disclosed is the use of faba bean meal in microbial fermentation to decrease the viscosity of the fermentation broth as compared to using a complex nitrogen source other than faba bean meal.
Patent NZ-561235-A (NZ)
Title: Idebenone for the treatment of muscular dystrophies
Inventor: MEIER THOMAS
IPC: A61K31/122
Filed: 2006-03-20
Abstract: Disclosed is the use of idebenone for the preparation of a medicament for the treatment and/or prophylaxis of weakness and/or loss of skeletal muscle tissue and/or cardiomyopathy associated with a muscular dystrophy.
Patent NZ-564471-A (NZ)
Title: Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
Inventor: LENZ HELMUT
IPC: G01N33/53
Filed: 2006-07-05
Abstract: Provided is a method of assessing the efficacy of a therapy with a therapeutic antibody in a patient by detecting the target antigen of the therapeutic antibody in a sample obtained from the patient under therapy with the therapeutic antibody, said method comprising the steps of (a) providing the sample to be analyzed, (b) incubating said sample in solution with said therapeutic antibody under conditions appropriate for binding of solid therapeutic antibody to said target antigen, whereby a target antigen-therapeutic antibody-complex is formed with the total target antigen being complexed by the therapeutic antibody, and (c) detecting the complex formed in (b).
Patent NZ-566435-A (NZ)
Title: A flexible knitting pin
Inventor: DEVAGNANAM T
IPC: D04B3/02
Filed: 2006-10-23
Abstract: A flexible knitting pin and a process for manufacturing the flexible knitting pin is disclosed. The knitting pin includes two relatively stiff shanks having first and second ends, where each shank is pointed at the first end and has a ferrule which holds a ball head screw at the second end. The second ends of the shanks are connected with each other by a flexible hollow connecting material comprising a joint. A brass adapter connects each shank with the flexible hollow connecting material for smooth transition.
Patent NZ-568990-A (NZ)
Title: Hinge system/visor attachment
Inventor: SPINK GLEN ERNEST
IPC: A42B3/22
Filed: 2008-06-06
Abstract: A helmet 27 with an articulated or pivoted visor 2, where the visor 2 is biased to move to the lowered position by a biasing mechanism 5.. The visor 2 is releasably held in one of either the raised or lowered position by a locking mechanism, and can be released by moving it further in that direction. This arrangement allows easier raising or lowering of the visor 2.
Patent NZ-569937-A (NZ)
Title: Fastening bracket for a chair that holds the crotch strap of a harness passing through the seat of the chair
Inventor: OPSVIK PETER
IPC: A44B11/25
Filed: 2007-02-23
Abstract: A fastening bracket (10) for use in attaching a harness (100) to a children's chair (1) is disclosed. The seat (2) has a vertical opening thought which a crotch strap (101) passes. The bracket has a frame piece (10) with a vertical first opening (11), for placement on the underside of the seat plate (2). A lining clip with two parallel vertical locking pegs is placed into the opening in the seat plate (2) from above and the harness (101 is passed though an opening in the clip and the frame piece then secured by a locking pin. The locking pin has two parallel arms which connect to the locking pegs, the arms being connected by a pin cross piece which is passed through a loop in the harness crotch strap (101).
Patent NZ-578812-A (NZ)
Title: Surgical helmet and cover assembly, methods of making and using the same
Inventor: DILLON MARK S
IPC: A41D13/05
Filed: 2008-02-26
Abstract: A surgical helmet cover assembly 100 comprises a hood sized to extend over a surgical helmet, the hood comprising a first hood material 102 having a face shield aperture 103, air inlet 104, air outlet 105 and a hood opening 136 all of which are completely surrounded by the first hood material 102, a transparent face shield 106 and additional pieces of hood material positioned over the air inlet 104 and air outlet 105. The hood opening 136 is sized so that the hood can be positioned over and onto a surgical helmet. The transparent face shield 106 is positioned over the face shield aperture 103 and bonded to the first hood material 102 along an outer periphery of the face shield aperture 103 so as to form a sterile barrier between an interior volume of the hood and an exterior surface of the hood. The additional pieces of hood material are bonded to the first hood material 102 along the outer periphery of the hood air inlet 104 and the hood air outlet 105, and have air flow permeability greater than that of the first hood material 102.
Patent NZ-582349-A (NZ)
Title: Heterocyclic compounds useful as raf kinase inhibitors
Inventor: COSSROW JENNIFER
IPC: A61K31/505
Filed: 2008-06-30
Abstract: Disclosed is a pyrimidine amide of formula I or a pharmaceutically acceptable salt thereof, wherein the substituents are defined in the specification for the treatment of a proliferative disorder, a cardiac disorder, a neurodegenerative disorder, an autoimmune disorder, a condition associated with organ transplant, an inflammatory disorder, an immunologically-mediated disorder, a viral disease, or bone disorder.
Patent NZ-582677-A (NZ)
Title: 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
Inventor: VAZ ROY
IPC: C07D515/06
Filed: 2008-06-26
Abstract: Disclosed is a pyridazine substituted imidazole of formula (I) where the substituents are as disclosed in the description and examples of compounds of formula (I) are: 2-Phenyl-6-piperazin-1-yl-3-pyrid-4-yl imidazo[1,2-b] pyridazine; 2-(4-Fluorophenyl)-6-piperazin-1-yl-3-pyrid-4-ylimidazo[1,2-b]pyridazine; and 2-(4-FluorophenyI)-7,8-dimethyI-6-piperazin-1-yl-3-pyrid-4-ylimidazo[1,2-b]pyridazine. Also disclosed is a process for preparing a compound of formula (I), a medicament or a pharmaceutical composition comprising a compound of formula (I), the use of a compound of formula (I) in the preparation of a medicament for treating sleep disorders, circadian rhythm disorders, dependence on abusive substances, diseases related to hyperphosphorylation of the tau protein, diseases caused by cell proliferation.
Patent NZ-585921-A (NZ)
Title: Hydrolysis resistant organomodified disiloxane ionic surfactant compositions and aqueous emulsion thereof
Inventor: LEATHERMAN MARK D
IPC: C09K23/54
Filed: 2008-12-26
Abstract: An asymmetric organo-modified disiloxane surfactant having the formula: MM' is disclosed, wherein M comprises branched hydrocarbon substituents and M' comprises a cationic, anionic or zwitterionic substituent and a polyether substituent that may be combined as one moiety, which are further defined in the specification, wherein the disiloxane surfactant has an enhanced resistance to hydrolysis between a pH of about 3 to about 12. The disclosure also relates to a composition comprising said asymmetric organo-modified disiloxane surfactant and a component selected from the group consisting of agricultural components, coating components, personal care components, home care components, oil or gas treating components, water processing components, and pulp or paper treating components. Further disclosed are aqueous emulsions where the discontinuous phase comprises water and the continuous phase comprises said composition mixture, or vice versa.
Patent NZ-586125-A (NZ)
Title: Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
Inventor: SHERMAN BARRY M
IPC: A61P35/00
Filed: 2008-11-11
Abstract: Disclosed is the use of a combination of 4-iodo-3-nitrobenzamide (BA), or a metabolite or a pharmaceutically acceptable salt thereof, at least one antitumor antimetabolite, such as gemcitabine, and at least one antitumor platinum complex, such as carboplatin, in the treatment of breast cancer that is negative for oestrogen receptor ("ER"), progesterone receptor ("PR"), and human epidermal growth factor 2 receptor ("HER2"). The combination is useful for treating infiltrating duct carcinoma breast cancer, including where the breast cancer is metastatic.
Patent NZ-590615-A (NZ)
Title: Re-useable auto-injector with filling means and method of priming the device
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/178
Filed: 2009-06-10
Abstract: An auto-injector having a first sub-assembly. The first sub-assembly includes a housing, a chamber disposed within the housing and having proximal and distal ends, an inner surface and an exit aperture. The first sub-assembly also includes a stopper movably disposed within the chamber and having an outer surface in contact with the inner surface about its perimeter, and a port movable in relation to the housing and coupled to the chamber such that movement of the port causes a corresponding movement of the chamber and the exit aperture, relative to the housing, the port adapted to receive a container containing a fluid. When the port and the chamber are moved in relation to the housing, the stopper remains stationary with respect to the housing such that movement of the port causes movement of the exit aperture in relation to the stopper.
Patent NZ-597818-A (NZ)
Title: Probiotic derived non-viable material for allergy prevention and treatment
Inventor: RENZ HARALD
IPC: A23L29/00
Filed: 2010-09-10
Abstract: NZ 597818 Disclosed is a nutritional product including a composition comprising a proteinaceous mixture, wherein said composition is obtained from a culture supernatant in a late-exponential phase of a Lactobacillus rhamnosus GG (LGG) batch-cultivation process, for use in the treatment or prevention of allergic diseases.
Patent NZ-599279-A (NZ)
Title: Nebulizer
Inventor: HOLAKOVSKY HOLGER
IPC: A61M15/00
Filed: 2010-11-22
Abstract: 599279 A nebuliser (1), in particular an inhaler, for a liquid having a pre-installed container. The nebuliser (1) has an insertable container (3) containing the liquid, the container (3) comprising a fluid outlet (24) for the liquid, the fluid outlet (24) being closed by a first closure (25) in a delivery state of the nebuliser (1). The container (3) is already disposed in the nebuliser (1) in the delivery state, the nebuliser (1) comprising a conveying element for conveying the liquid from the container (3) to the nebuliser (1). The nebuliser (1) is constructed so that the first closure (25) and, thus, the fluid outlet (24) are opened inside the nebuliser (1) before or during first use of the nebuliser (1) by insertion of the conveying element. The conveying element is already partly inserted into the container (3) in the delivery state without opening the first closure (25).
Patent NZ-599430-A (NZ)
Title: A drug delivery system for the prevention of cerebral vasospasm
Inventor: R LOCH MACDONALD
IPC: A61K31/553
Filed: 2008-06-11
Abstract: NZ 599430 Disclosed is a site-specific, microparticulate pharmaceutical composition comprising: a therapeutic amount of a therapeutic agent, wherein the therapeutic agent comprises an Endothelin (ET) receptor antagonist; a Transient Receptor Potential (TRP) channel antagonist, or a combination thereof; and a pharmaceutically acceptable carrier, wherein the carrier comprises a plurality of microparticles, the composition being characterised by: dispersal of the therapeutic agent throughout each microparticle; sustained release of the therapeutic agent from the composition; as a dispersion, its fluidity around the cerebral artery at risk for vasospasm following local delivery via injection; and a local therapeutic effect that is effective to reduce risk of vasospasm without entering systemic circulation in an amount to cause unwanted side effects. Also disclosed is the use of said microparticulate pharmaceutical composition in the manufacture of a medicament for the treatment of a cerebral artery at risk for cerebral vasospasm in a human subject, wherein the microparticulate pharmaceutical composition is formulated to be administered to the human subject locally via injection into a subarachnoid space in a cistern closest to a cerebral artery at risk for vasospasm.
Patent NZ-600672-A (NZ)
Title: A jug
Inventor: STREET SARAH JANE
IPC: A47G19/12
Filed: 2009-12-15
Abstract: 600176 A jug (100) is disclosed that is adapted for use on an aircraft. The jug has a container portion with a base (110) and an upper opening (130) that are in non-parallel planes (111, 131). The jug is symmetrical about a central vertical plane extending between the spout (140) and the central axis (121). The central axis (121) of the container portion is angled with respect to the plane of the base (111). The geometry compensates for the angle of an aircraft in flight and reduces wrist strain.